iNetworks

iNetworks BioMedical Advisors is a venture capital firm based in Pittsburgh, Pennsylvania, established in 1999. The firm specializes in providing strategic management and business development support to companies and research institutions within the biotechnology, pharmaceutical, medical device, diagnostic, and healthcare sectors. iNetworks focuses on investing in information technology and life science companies, aiming to accelerate their growth while delivering strong returns for investors. Through its Opportunity Fund, the firm targets opportunities specifically in healthcare and information technology, positioning itself as a key player in these dynamic industries.

Greg Auner

Managing Director

Joseph Donohue

Analyst

Gary N. Keller

Managing Director

Anthony Lacenere

Co-Founder and Senior Managing Partner

Charlie Schlieb

Co-Founder and Managing Director

7 past transactions

Wenzel Spine

Venture Round in 2021
Wenzel Spine, Inc. is a medical technology company focused on providing minimally invasive solutions for the treatment of spinal disorders. The company focused on delivering surgical solutions that improve the overall quality of spine care by simplifying procedures and reducing recovery time. Wenzel Spine seeks to improve the life of a patient by designing and producing devices to support our surgeon clients in the care and treatment of their patients. It also provides VariLift-L, VariLift-A, VariLift-LX, VariLift Interbody Fusion System, and VariLift-C.' Wenzel Spine was founded in 2008 and is headquartered in Texas, USA.

Wenzel Spine

Series C in 2018
Wenzel Spine, Inc. is a medical technology company focused on providing minimally invasive solutions for the treatment of spinal disorders. The company focused on delivering surgical solutions that improve the overall quality of spine care by simplifying procedures and reducing recovery time. Wenzel Spine seeks to improve the life of a patient by designing and producing devices to support our surgeon clients in the care and treatment of their patients. It also provides VariLift-L, VariLift-A, VariLift-LX, VariLift Interbody Fusion System, and VariLift-C.' Wenzel Spine was founded in 2008 and is headquartered in Texas, USA.

PennAlt Organics

Series A in 2016
PennAlt is a pharmaceutical company that focuses on neurological disorders.The company's products specialize in the treatment of disorders related to brain, spine and the nerves by providing medical marijuana at an appropriate and consistent dosage, enabling patients to alleviate pain and suffering and recover from their disorders at a faster rate.

Unequal

Series B in 2016
Unequal Technologies manufactures advanced body armor solutions designed for protection in various sports and military applications. Founded in 2008 by Robert Vito in Glen Mills, Pennsylvania, the company developed a revolutionary composite material, fortified with DuPont Kevlar®, that is lightweight yet effective in stopping bullets and dispersing impact energy. Initially created for military use, this technology has been adopted in professional sports, with products such as headgear, helmet liners, protective shirts, and cushioning insoles gaining popularity among athletes in leagues like the NFL, NHL, and Major League Baseball. The company's protective gear is tailored for various sports, including soccer, baseball, lacrosse, and football, and is designed to be affordable and customizable for specific applications. Unequal Technologies has received multiple awards for innovation, including recognition from Forbes and the Kevlar® Innovation Award from DuPont, showcasing its significant impact on the protective sportswear industry.

Novian Health

Series A in 2014
Novian Health Inc., based in Chicago, specializes in innovative medical technology aimed at treating tumors through a minimally invasive procedure known as Novilase. This proprietary system utilizes Interstitial Laser Therapy (ILT) to ablate both benign and malignant breast tumors, offering a less invasive alternative to traditional lumpectomy surgery. Novilase provides significant benefits, including minimal scarring, faster recovery times, and the need for only local anesthesia. The company has successfully obtained FDA 510(k) market clearance for treating benign breast tumors, with ongoing clinical trials aimed at securing approval for malignant tumors. Novian Health's products are accessible at various breast centers across the United States, underscoring its commitment to enhancing cancer treatment options.

Novian Health

Series A in 2013
Novian Health Inc., based in Chicago, specializes in innovative medical technology aimed at treating tumors through a minimally invasive procedure known as Novilase. This proprietary system utilizes Interstitial Laser Therapy (ILT) to ablate both benign and malignant breast tumors, offering a less invasive alternative to traditional lumpectomy surgery. Novilase provides significant benefits, including minimal scarring, faster recovery times, and the need for only local anesthesia. The company has successfully obtained FDA 510(k) market clearance for treating benign breast tumors, with ongoing clinical trials aimed at securing approval for malignant tumors. Novian Health's products are accessible at various breast centers across the United States, underscoring its commitment to enhancing cancer treatment options.

Vital Sensors

Venture Round in 2006
Vital Sensors, a medical device company, develops a remote cardiac sensor for congestive heart failure patients in the United States. Its remote cardiac sensors provide on-demand data monitoring for patients with cardiovascular diseases in hospitals and homes. The company was formerly known as Vital Sensors GmbH. Vital Sensors, Inc. was founded in 2002 and is headquartered in Richmond, Virginia.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.